GLP1-RAs and Type 1 Diabetes: A retrospective study of incretin-based therapy use with Open Source AID.
So far in this series we’ve looked at why incretin therapy might be a useful adjunct to traditional type 1 treatment, and also how the […]
So far in this series we’ve looked at why incretin therapy might be a useful adjunct to traditional type 1 treatment, and also how the […]
As we discussed in the previous article, people are starting to use incretins as an adjunct therapy in the treatment of type 1 diabetes. All […]
Some people will be aware, and some not, that there is a reasonable minority of people with Type 1 Diabetes using GLP-1 Receptor Agonists (GLP1-RAs) […]
In all the noise around EASD, you may not have noticed that Microtech have launched a new CGM. This is their follow up to Aidex, […]
Following action from users, admins, healthcare staff and advocates, Abbott have responded on the takedown shenanigans. This seems to be a company statement that has […]
Over the past 48 hours, numerous Facebook groups across Europe that were unaffiliated with Abbott but provided “User group” services to Freestyle Libre users received […]
With performance numbers on the new 15-day, prescription free, Stelo sensor from Dexcom looking very similar to those from the G7, could Dexcom be contemplating the announcement of an uldated 15-day iCGM at EASD in Madrid?
There are regularly calls in the #WeAreNotWaiting world to incorporate exercise detection into the algorithms that we use, so that end users can minimise hypo […]
Ever since the Omnipod appeared, the question over what type of pump to use has been a constant question from both new users and those […]
Breaking news in the world of Diabetes tech today saw Medtronic and Abbott share news of a partnership to provide Abbott CGM technology to Medtronic […]
Copyright © 2026 | WordPress Theme by MH Themes